By tove [dot] smeds [at] med [dot] lu [dot] se (Tove Smeds) - published 21 October 2022 Dopamine-producing neurons that researchers from Lund University have grown in the laboratory from human embryonic stem cells (Photo: Agneta Kirby) An investigational stem cell-based therapy for the treatment of Parkinson’s Disease, STEM-PD, has been given regulatory approval for a Phase I/IIa clinical trial. E

https://www.multipark.lu.se/article/swedish-medical-products-agency-grants-approval-clinical-study-new-stem-cell-based-parkinsons - 2025-07-11

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 28 October 2022 Matilde Negrini defends her thesis 4 November 2022. Matilde Negrini’s thesis project has been to develop and characterize a rat model of Parkinson’s disease. November 4, she defends her thesis. Here, she talks about her project and most proud moments during her Ph.D. journey. Tell us about your rese

https://www.multipark.lu.se/article/modelling-parkinsons-disease-phd-interview-matilde-negrini - 2025-07-11

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 7 November 2022 Oskar Hansson, research-leader at MultiPark, recently met with Bill Gates to discuss biomarkers for Alzheimer's disease. MultiPark’s scientists conduct world-leading research in biomarkers for Alzheimer’s disease, led by Professor Oskar Hansson at the memory clinic at Skåne University Hospital. He r

https://www.multipark.lu.se/article/multipark-researcher-bill-gates-brussels - 2025-07-11

By press [at] med [dot] lu [dot] se (Medical Faculty) - published 17 November 2022 In a large international research study with 1,300 participants from, among other places, Sweden, the USA, the Netherlands and Australia, PET cameras could detect the presence of the proteins tau and amyloid in the participants' brains. iStock/baranozedem A large study led by Lund University in Sweden has shown that

https://www.multipark.lu.se/article/alzheimers-disease-can-be-diagnosed-symptoms-emerge - 2025-07-11

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 22 November 2022 Inducible viral vectors can be used to investigate the effect of human alpha synucelin on dopamine release and reuptake inside the rodent brain. Photo: Andreas Heuer's group. MultiPark’s backbone for research interactions is about to be reorganized. The 13 new special interest groups (SIGs) address

https://www.multipark.lu.se/article/brain-circuit-analysis-special-interest-group - 2025-07-11

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 23 November 2022 Roberta Battistella defends her thesis 1 December 2022. The glymphatic system clears waste products from the brain. Roberta Battistella defends her thesis about the role of this system in Parkinson’s disease on December 1. Here, she tells about her time as a Ph.D student in Iben Lundgaards research

https://www.multipark.lu.se/article/glymphatic-system-pd-phd-interview-roberta-battistella - 2025-07-11

By Press [at] med [dot] lu [dot] se (Medical Faculty) - published 29 November 2022 A microglia (Image: iStock/slevaneara) The brain's big-eating immune cells can slow down the progression of Alzheimer's disease. This is shown by a study that is now published in Nature Aging. The brain's own immune cells are called microglia and are found in the central nervous system. They are big eaters that kill

https://www.multipark.lu.se/article/brains-immune-cells-can-be-triggered-slow-down-alzheimers-disease - 2025-07-11

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 2 December 2022 Magnus Lindh-Rengifo defends his thesis 16 December 2022. Walking is probably more cognitively demanding than you think. Magnus Lindh-Rengifo defends his thesis about walking aspects in neurodegenerative disorders on December 16. Read about his experiences as a Ph.D student at MultiPark. Tell us abo

https://www.multipark.lu.se/article/walking-neurodegeneration-phd-interview-magnus-lindh-rengifo - 2025-07-11

Published 3 January 2023 Foto: iStock/andresr. A new study have identified which blood tests are best at detecting Alzheimer’s disease during the earliest stages, and also another blood test that is optimal for detecting relevant treatment effects. These findings will speed up the development of new therapies that can slow down the disease progression. The article was originally published as a pre

https://www.multipark.lu.se/article/optimal-blood-tests-development-new-therapies-alzheimers-disease - 2025-07-11

By helga [dot] heun [at] er [dot] lu [dot] se (Helga Heun) - published 8 December 2022 Photo: Johan Wingborg, University of Gothenburg. “Lundensare” Nobel Prize winner Arvid Carlsson (1923-2018) did not receive the prestigious Nobel Prize while living or working in Lund – but he is an alumnus! Carlsson grew up in Lund (which could clearly be heard in his Lund accent) and in 1951 he became a doctor

https://www.multipark.lu.se/article/nobel-prize-winner-arvid-carlsson-7-things-you-perhaps-did-not-know-about-him-and-his-research - 2025-07-11

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 14 December 2022 In substantia nigra, neurons expressing Calretinin seem to be more resistant to damage. Photo: Lautaro Belfiori. MultiPark’s new special interest groups (SIGs) address essential scientific and technological needs and provide opportunities for professional development and network formation to our yo

https://www.multipark.lu.se/article/molecular-signaling-neurodegenerative-disorders-special-interest-group - 2025-07-11

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 13 January 2023 Keivan Javanshiri defends his thesis 20 January 2023. Profile photo:Tove Smeds. Keivan Javanshiri’s Ph.D. project explores cardiac and vascular pathologies in Lewy body dementia and Alzheimer's disease. January 20, he defends his thesis. Here, he shares the most important findings and why sudden car

https://www.multipark.lu.se/article/cognitive-disease-beyond-brain-phd-interview-keivan-javanshiri - 2025-07-11

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 21 December 2022 We ended the MultiPark year in December as we started it in January: with a MultiPark Retreat! The December retreat was our first big meeting IRL after the pandemic, and it turned out to be a much appreciated event. Thank you to all participants, and thank you once again to the retreat organizing c

https://www.multipark.lu.se/article/multipark-closing-circle-2022-and-looking-forward-2023 - 2025-07-11

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 10 January 2023 Katrine Skovgård defends her thesis 19 January 2023. Katrine Skovgård’s Ph.D. project sheds light on the dysfunctions in the brain through which dopaminergic pharmacotherapies for Parkinson’s disease affect motor behaviors. January 19, she defends her thesis. She explains how better experimental mod

https://www.multipark.lu.se/article/why-dopamine-receptor-type-matters-phd-interview-katrine-skovgard - 2025-07-11

By tove [dot] smeds [at] med [dot] lu [dot] se (Tove Smeds) - published 12 January 2023 Dopamine-producing neurons that researchers from Lund University have grown in the laboratory from human embryonic stem cells. Photo: Agnete Kirkeby. At the end of October 2022, the Swedish Medical Products Agency gave the go-ahead for a clinical trial of the stem cell-based therapy STEM-PD for the treatment of

https://www.multipark.lu.se/article/nerve-cells-could-transform-treatment-parkinsons - 2025-07-11

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 3 February 2023 Elna Dickson defends her thesis 17 February 2023. Huntington's disease is known as the "dance disease" due to the patient's characteristic motor symptoms. However, Elna Dickson's Ph.D. project shows that the disease also leads to pathological changes outside the brain. February 17, she defends her t

https://www.multipark.lu.se/article/huntingtons-metabolic-dysfunctions-phd-interview-elna-dickson - 2025-07-11

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 10 February 2023 Tomas Roos defends his thesis 17 February 2023. The aggregation of the protein Amyloid-beta (Abeta) into plaques outside the nerve cells has been recognized in patients with Alzheimer’s disease since 1905. But eliminating the plaques has not helped patients so far. Still, Tomas Roos thinks that Abe

https://www.multipark.lu.se/article/does-alzheimers-disease-start-inside-neurons-phd-interview-tomas-roos - 2025-07-11

By tove [dot] smeds [at] med [dot] lu [dot] se (Tove Smeds) - published 28 February 2023 The milestone transplant was performed at Skåne University Hospital in February. On 13th of February, a transplant of stem cell-derived nerve cells was administered to a person with Parkinson’s at Skåne University Hospital, Sweden. The product has been developed by Lund University and it is now being tested in

https://www.multipark.lu.se/article/first-patient-receives-milestone-stem-cell-based-transplant-parkinsons-disease - 2025-07-11

By press [at] liu [dot] se (Mikael Sönne) - published 8 March 2023 With the injectable gel the researchers were able to grow electrodes in living tissue. Here it is tested on a microfabricated circuit. Photo: Thor Balkhed/Linköpings universitet The boundaries between biology and technology are becoming blurred. Researchers at Linköping, Lund, and Gothenburg universities in Sweden have successfully

https://www.multipark.lu.se/article/electrodes-grown-brain - 2025-07-11

By martina [dot] svensson [at] med [dot] lu [dot] se (Martina Svensson) - published 20 March 2023 Kajsa Brolin defends her thesis 27 March 2023. Photo: Kennet Ruona Kajsa Brolin explores how our genes and environment affect the risk of developing Parkinson’s disease. March 27, she defends her Ph.D. project partly based on MultiPark’s biobank sample collection. Here, she tells about the newly disco

https://www.multipark.lu.se/article/genes-and-environment-pd-phd-interview-kajsa-brolin - 2025-07-11